Blackbaud Customers Around the World Rely on Technology to Support COVID-19 Research and Innovation

By AIT News Desk On Jun 5, 2020

Higher education and healthcare institutions turn to Blackbaud solutions to power fundraisers for COVID-19 vaccines, lifesaving equipment

Blackbaud, the world’s leading cloud software company powering social good, is supporting key higher education and healthcare institutions around the world with the technology needed to effectively fundraise for COVID-19 research and essential equipment, including potential vaccine breakthroughs, low-cost ventilator production and methods to treat the virus and slow its spread.

“Throughout the world, many of our customers are on the frontlines of COVID-19 relief and having the cloud software in place to support their missions has never been more critical,” said Mike Gianoni, president and CEO, Blackbaud. “We have been continually amazed by our customers globally and their ingenuity during this time and are proud to support their efforts through reliable and highly effective technology.”

NetApp Joins the Vultr Cloud Alliance to Provide Scalable Data Management for Enterprise AI Workloads

Nov 25, 2024

Smodin Unites Powerful Domains to Deliver an All-in-One AI Platform

Nov 25, 2024

Cerebras Appoints Tom Lantzsch to Board of Directors

Nov 25, 2024

Prev Next 1 of 40,604

Fundraising for COVID-19 Vaccine Research in Australia

Blackbaud recently helped the University of Queensland (UQ) in Brisbane, Australia launch a peer-to-peer fundraising campaign for COVID-19 vaccine research. Blackbaud’s leading peer-to-peer fundraising solutions enable social good organizations to quickly create fundraising campaigns driving current and new supporters to share their passion for an organization’s mission. UQ researchers need to raise $4.5 million in addition to the support they’ve received from the government and philanthropic partners, to help them develop a vaccine to end COVID-19.

“We are incredibly grateful for Blackbaud’s support in our efforts to facilitate philanthropic giving to accelerate COVID-19 vaccine development at The University of Queensland,” said Jennifer Karlson, pro-vice-chancellor of advancement, University of Queensland. “The technology has been a critical gateway for the UQ community to give to this important cause.”